Stock Information
CorMedix Inc (CRMD)
Ticker Symbol: CRMD
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $595.25 mil
Piotroski score: 2
PE Ratio: 3.5279
EPS (TTM): 2.0988
Revenue (TTM): $4.30 M
Dividend Yield: N/A%
ROE: 50.38%
Latest News
-
RBC Capital Maintains Outperform on Cormedix, Raises Price Target to $14
Fri, Aug 14, 2026 11:26 AM
-
There are notable gap-ups and gap-downs in today's session.
Thu, Aug 13, 2026 2:30 PM
-
CorMedix Inc. (CRMD) Q2 2026 Earnings Call Transcript
Thu, Aug 13, 2026 1:47 PM
-
CorMedix Stock Jumps on Strong DefenCath Sales
Thu, Aug 13, 2026 10:56 AM
-
Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday
Thu, Aug 13, 2026 9:57 AM
-
Full Transcript: Cormedix Q2 2026 Earnings Call
Thu, Aug 13, 2026 9:07 AM
-
Cormedix Affirms FY2026 Sales Guidance of $325.000M-$345.000M vs $334.089M Est
Thu, Aug 13, 2026 7:30 AM
Key Financials
Financial data not available
